“Adults with congenital heart defects”: current challenges in medical care. Part II: infective endocarditis, pulmonary hypertension, aortopathy, cardiac surgical aspects, psychocardiology, unresolved problems and future aspects
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kuijpers JM, Koolbergen DR, Groenink M, Peels KCH, Reichert CLA, Post MC et al (2017) Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 38(26):2048–2056
Tutarel O, Alonso-Gonzalez R, Montanaro C, Schiff R, Uribarri A, Kempny A et al (2018) Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart 104(2):161–165
Philip M, Tessonier L, Mancini J, Mainardi JL, Fernandez-Gerlinger MP, Lussato D et al (2020) Comparison between ESC and duke criteria for the diagnosis of prosthetic valve infective endocarditis. JACC Cardiovasc Imaging 13(12):2605–2615
Ishikita A, Sakamoto I, Yamamura K, Umemoto S, Nagata H, Kitamura Y et al (2021) Usefulness of (18)F-Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of infective endocarditis in patients with adult congenital heart disease. Circ J 85(9):1505–1513
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al (2015) 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075–3128
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30(19):2369–2413
Naber C, Al-Nawas B, Baumgartner H, Becker H‑J, Block M, Erbel R, Ertl G, Franzen D, Gohlke-Bärwolf C, Gattringer R, Graninger W, Handrick W, Heying R, Horstkotte D, Jaussi A, Kern P, Kramer H‑H, Kühl S, Lepper PM, Leyh RG, Lode H, Mehlhorn U, Moreillon P, Mügge A, Mutters R, Peters G, Rosenhek R, Schmaltz AA, Seifert H, Shah PM, Sitter H, Wagner W, Wahl G, Werdan K, Zuber M (2007) Prophylaxe der infektiösen Endokarditis. Kardiologe 1:243–250
Muller N, Breuer J, Adler K, Freudenthal NJ (2021) “Body modification: piercing and tattooing in congenital heart disease patients”, decoration or disaster?—a narrative review. Cardiovasc Diagn Ther 11(6):1395–1402
Stammnitz C, Huscher D, Bauer UMM, Urban A, Nordmeyer J, Schubert S et al (2022) Nationwide registry-based analysis of infective endocarditis risk after pulmonary valve replacement. J Am Heart Assoc 11(5):e22231
McElhinney DB, Zhang Y, Aboulhosn JA, Morray BH, Biernacka EK, Qureshi AM et al (2021) Multicenter study of Endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol 78(6):575–589
Duval X, Alla F, Hoen B, Danielou F, Larrieu S, Delahaye F et al (2006) Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 42(12):e102–e107
Poorzand H, Hamidi F, Sheybani F, Ghaderi F, Fazlinezhad A, Alimi H et al (2022) Infective endocarditis: clinical characteristics and Echocardiographic findings. Front Cardiovasc Med 9:789624
Mano TB, Cardoso I, Costa PO, Rito T, Branco L, Agapito A et al (2022) Infective endocarditis in a cohort of adult CHD patients. Cardiol Young. https://doi.org/10.1017/S1047951122000403
Kunkel M (2022) Endokarditisprophylaxe: Entwicklungen und aktuelle Empfehlungen. zm (10). ISBN: 978–3–86867–552–8
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP et al (2021) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42(6):563–645
Diller GP, Gatzoulis MA (2007) Pulmonary vascular disease in adults with congenital heart disease. Circulation 115(8):1039–1050
Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW et al (2007) Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 120(2):198–204
Lammers AE, Bauer LJ, Diller GP, Helm PC, Abdul-Khaliq H, Bauer UMM et al (2020) Pulmonary hypertension after shunt closure in patients with simple congenital heart defects. Int J Cardiol 308:28–32
van Riel AC, Schuuring MJ, van Hessen ID, Zwinderman AH, Cozijnsen L, Reichert CL et al (2014) Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol 174(2):299–305
Zimmermann R, Schranz D, Ewert P, Kaemmerer H (2013) Pulmonary arterial hypertension in congenital heart defects with shunt: a heterogeneous and complex constellation. Dtsch Med Wochenschr 138(23):1244–1246
Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galie N (2014) Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J 35(11):716–724
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M et al (2022) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. https://doi.org/10.1093/eurheartj/ehac237
Kaemmerer H, Apitz C, Brockmeier K, Eicken A, Gorenflo M, Hager A et al (2018) Pulmonary hypertension in adults with congenital heart disease: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 272:79–88
Babu-Narayan SV, Giannakoulas G, Valente AM, Li W, Gatzoulis MA (2016) Imaging of congenital heart disease in adults. Eur Heart J 37(15):1182–1195
D’Alto M, Dimopoulos K, Budts W, Diller GP, Di Salvo G, Dellegrottaglie S et al (2016) Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension. Heart 102(12):910–918
Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16(3):233–270
Zamorano JL, Bax J, Knuuti J, Badano L, Lancellotti P (2015) The ESC textbook of cardiovascular imaging. Oxford University Press
Bedard E, Dimopoulos K, Gatzoulis MA (2009) Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 30(3):256–265
Galie N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A et al (2006) Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 114(1):48–54
D’Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N et al (2012) Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. Int J Cardiol 155(3):378–382
Iversen K, Jensen AS, Jensen TV, Vejlstrup NG, Sondergaard L (2010) Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. Eur Heart J 31(9):1124–1131
Cha KS, Cho KI, Seo JS, Choi JH, Park YH, Yang DH et al (2013) Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study). Am J Cardiol 112(11):1834–1839
van Riel AC, Blok IM, Zwinderman AH, Wajon EM, Sadee AS, Bakker-de Boo M et al (2015) Lifetime risk of pulmonary hypertension for all patients after shunt closure. J Am Coll Cardiol 66(9):1084–1086
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galie N, Ghofrani HA et al (2013) Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 369(9):809–818
Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galie N et al (2015) Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med 373(26):2522–2533
Kaemmerer AS, Freilinger S, Andonian C, Ewert P, Havasi K, Nagdyman N et al (2021) Provision of medical health care for adults with congenital heart disease associated with aortic involvement. Cardiovasc Diagn Ther 11(2):518–528
Kuijpers JM, Mulder BJ (2017) Aortopathies in adult congenital heart disease and genetic aortopathy syndromes: management strategies and indications for surgery. Heart. https://doi.org/10.1136/heartjnl-2015-308626
May Khan A, Kim Y (2014) Aortic dilatation and aortopathies in congenital heart disease. Curr Opin Cardiol 29(1):91–96
Niwa K (2005) Aortic root dilatation in tetralogy of Fallot long-term after repair—histology of the aorta in tetralogy of Fallot: evidence of intrinsic aortopathy. Int J Cardiol 103(2):117–119
Niwa K (2018) Aortic dilatation in complex congenital heart disease. Cardiovasc Diagn Ther 8(6):725–738
Francois K (2015) Aortopathy associated with congenital heart disease: A current literature review. Ann Pediatr Cardiol 8(1):25–36
Niwa K, Perloff JK, Bhuta SM, Laks H, Drinkwater DC, Child JS et al (2001) Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103(3):393–400
von Kodolitsch Y, Rybczynski M, Vogler M, Mir TS, Schüler H, Kutsche K et al (2016) The role of the multidisciplinary health care team in the management of patients with Marfan syndrome. J Multidiscip Healthc 9:587
Neidenbach R, Niwa K, Oto O, Oechslin E, Aboulhosn J, Celermajer D et al (2018) Improving medical care and prevention in adults with congenital heart disease—Reflections on a global problem—part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy. Cardiovasc Diagn Ther 8(6):716–724
Zanjani KS, Niwa K (2013) Aortic dilatation and aortopathy in congenital heart diseases. J Cardiol 61(1):16–21
Niwa K (2013) Aortopathy in congenital heart disease in adults: Aortic dilatation with decreased aortic elasticity that impacts negatively on left ventricular function. Korean Circ J 43(4):215–220
Senzaki H, Iwamoto Y, Ishido H, Matsunaga T, Taketazu M, Kobayashi T et al (2008) Arterial haemodynamics in patients after repair of tetralogy of Fallot: influence on left ventricular after load and aortic dilatation. Heart 94(1):70–74
Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H et al (2014) 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J 35(41):2873–2926
Di Salvo G, Miller O, Narayan BS, Li W, Budts W, Valsangiacomo Buechel ER et al (2018) Imaging the adult with congenital heart disease: a multimodality imaging approach—Position paper from the EACVI. Eur Heart J Cardiovasc Imaging 19(10):1077–1098
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39.e14
von Kodolitsch Y, Kutsche K (2017) Genetic diagnostics of inherited aortic diseases: Medical strategy analysis. Herz 42(5):459–467
Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB et al (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47(7):476–485
Huntgeburth M, Neidenbach RC, von Kodolitsch Y, Kaemmerer H (2018) Genetisch bedingte Aortenerkrankungen – Empfehlungen für Kardiologen in Praxis und Klinik—Genetic Aortic Syndromes—Recommendations for Cardiologists in Practice and Clinic. Aktuel Kardiol 7(03):220–230
Beckmann A, Meyer R, Lewandowski J, Markewitz A, Blaßfeld D, Böning A (2022) German heart surgery report 2021: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 70(5):362–376
Vouhé PR (2011) Adult congenital surgery: current management. Semin Thorac Cardiovasc Surg 23(3):209–215
Klcovansky J, Søndergaard L, Helvind M, Andersen H (2008) Cardiac surgery in grown-up congenital heart patients. Will the surgical workload increase? Interact CardioVasc Thorac Surg 7(1):84–89
Berdat PA, Immer F, Pfammatter JP, Carrel T (2004) Reoperations in adults with congenital heart disease: analysis of early outcome. Int J Cardiol 93(2–3):239–245
Kindzelski BA, Bakaeen FG, Tong MZ, Roselli EE, Soltesz EG, Johnston DR et al (2022) Modern practice and outcomes of reoperative cardiac surgery. J Thorac Cardiovasc Surg 164(6):1755–1766.e16
Lemmer J, Heise G, Rentzsch A, Boettler P, Kuehne T, Dubowy KO et al (2011) Right ventricular function in grown-up patients after correction of congenital right heart disease. Clin Res Cardiol 100(4):289–296
Mauriat P, Bojan M, Soulie S, Foulgoc H, Tafer N, Ouattara A (2020) Impact of the perioperative inotropic support in grown-up congenital heart patients undergoing cardiac surgery: a propensity score adjusted analysis. Ann Intensive Care 10(1):91
Hosseinpour AR, Cullen S, Tsang VT (2006) Transplantation for adults with congenital heart disease. Eur J Cardiothorac Surg 30(3):508–514
Haapanen H, Tsang V, Kempny A, Neijenhuis R, Kennedy F, Cullen S et al (2020) Grown-up congenital heart surgery in 1093 consecutive cases: a “hidden” burden of early outcome. Ann Thorac Surg 110(5):1667–1676
van Rijen EH, Utens EM, Roos-Hesselink JW, Meijboom FJ, van Domburg RT, Roelandt JR et al (2004) Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 25(18):1605–1613
Albus C, Waller C, Fritzsche K, Gunold H, Haass M, Hamann B et al (2018) Bedeutung von psychosozialen Faktoren in der Kardiologie – Update 2018. Kardiologe 12(5):312–331
Nagdyman N, Huntgeburth M, Hager A, Neidenbach R, Ewert P, Kaemmerer H (2016) Belastungen bei Erwachsenen mit angeborenen Herzfehlern (EMAH): Sport, Beruf, Familienplanung und Schwangerschaft. Herzmedizin 16(26)
Kaemmerer H, Freilinger S, Neidenbach R, Achenbach S, Andonian C, Ewert P et al (2022) Versorgung von Erwachsenen mit angeborenen Herzfehlern in Deutschland – tragende Rolle von Internisten und Hausärzten. Internist 63(1):95–102
Fteropoulli T, Stygall J, Cullen S, Deanfield J, Newman SP (2013) Quality of life of adult congenital heart disease patients: a systematic review of the literature. Cardiol Young 23(4):473–485
Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW et al (2012) Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation 126(9):1143–1172
Neidenbach RC, Lummert E, Vigl M, Zachoval R, Fischereder M, Engelhardt A et al (2018) Non-cardiac comorbidities in adults with inherited and congenital heart disease: report from a single center experience of more than 800 consecutive patients. Cardiovasc Diagn Ther 8(4):423–431
Sliwa K, van der Meer P, Petrie MC, Frogoudaki A, Johnson MR, Hilfiker-Kleiner D et al (2021) Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail 23(4):527–540
Deng LX, Khan AM, Drajpuch D, Fuller S, Ludmir J, Mascio CE et al (2016) Prevalence and correlates of post-traumatic stress disorder in adults with congenital heart disease. Am J Cardiol 117(5):853–857
Jackson JL, Leslie CE, Hondorp SN (2018) Depressive and anxiety symptoms in adult congenital heart disease: Prevalence, health impact and treatment. Prog Cardiovasc Dis 61(3–4):294–299
Kovacs AH, Utens EM (2015) More than Just the heart: transition and psychosocial issues in adult congenital heart disease. Cardiol Clin 33(4):625–634
Kronwitter A, Mebus S, Neidenbach R, Tutarel O, Ewert P, Kaemmerer H et al (2019) Psychosocial situation in adults with congenital heart defects today and 20 years ago: Any changes? Int J Cardiol 275:70–76
Moons P, Bratt EL, De Backer J, Goossens E, Hornung T, Tutarel O et al (2021) Transition to adulthood and transfer to adult care of adolescents with congenital heart disease: a global consensus statement of the ESC Association of Cardiovascular Nursing and Allied Professions (ACNAP), the ESC Working Group on Adult Congenital Heart Disease (WG ACHD), the Association for European Paediatric and Congenital Cardiology (AEPC), the Pan-African Society of Cardiology (PASCAR), the Asia-Pacific Pediatric Cardiac Society (APPCS), the Inter-American Society of Cardiology (IASC), the Cardiac Society of Australia and New Zealand (CSANZ), the International Society for Adult Congenital Heart Disease (ISACHD), the World Heart Federation (WHF), the European Congenital Heart Disease Organisation (ECHDO), and the Global Alliance for Rheumatic and Congenital Hearts (Global ARCH). Eur Heart J 42(41):4213–4223
Kaemmerer H, Breithardt G (2006) Recommendations for the quality improvement of interdisciplinary care of adults with congenital heart anomalies. Clin Res Cardiol 95(Suppl 4):76–84
Kaemmerer H, Bauer U, de Haan F, Flesch J, Gohlke-Bärwolf C, Hagl S et al (2011) Recommendations for improving the quality of the interdisciplinary medical care of grown-ups with congenital heart disease (GUCH). Int J Cardiol 150(1):59–64
Westhoff-Bleck M, Briest J, Fraccarollo D, Hilfiker-Kleiner D, Winter L, Maske U et al (2016) Mental disorders in adults with congenital heart disease: Unmet needs and impact on quality of life. J Affect Disord 204:180–186
Andonian C, Beckmann J, Ewert P, Freilinger S, Kaemmerer H, Oberhoffer-Fritz R et al (2020) Assessment of the psychological situation in adults with congenital heart disease. J Clin Med 9(3):779
Diller GP, Körten MA, Bauer UM, Miera O, Tutarel O, Kaemmerer H et al (2016) Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects. Eur Heart J 37(18):1449–1455
Neidenbach R et al (2021) Systematic assessment of health care perception in adults with congenital heart disease in Germany. CDT-Journal. https://doi.org/10.21037/cdt-20-825
Kaemmerer H, Hess J (2009) Congenital heart disease. Transition from adolescence to adulthood. Internist (Berl) 50(10):1221–1227
Kaemmerer H, Andonian C, Ewert P, Freilinger S, Nagdyman N, Neidenbach R et al (2021) Transition – Nachsorge für Erwachsene mit angeborenen Herzfehlern. Dtsch Med Wochenschr 146(18):1192–1199
Baumgartner H, De Backer J (2020) The ESC clinical practice guidelines for the management of adult congenital heart disease 2020. Eur Heart J 41(43):4153–4154
Diller GP, Arvanitaki A, Opotowsky AR, Jenkins K, Moons P, Kempny A et al (2021) Lifespan perspective on congenital heart disease research. J Am Coll Cardiol 77(17):2219–2235